SARCULATOR 对比 Rad Onc Tables 的使用情况和统计数据

This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician. Two kinds of predictions are possible: - RPS: 5-year overall survival (OS) and 5-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. . - STS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.
  • Apple 应用商店
  • 免费
  • 医疗

商店排名

- -

A quick reference tool for finding, summarizing, and linking directly to research related to radiation oncology.
  • Apple 应用商店
  • 免费
  • 医疗

商店排名

- -

SARCULATOR与Rad Onc Tables排名比较

对比 SARCULATOR 与 Rad Onc Tables 在过去 28 天内的排名趋势

排名

没有可用的数据

SARCULATOR 对比 Rad Onc Tables 的排名,按国家/地区比较

对比 SARCULATOR 与 Rad Onc Tables 在过去 28 天内的排名趋势

无数据可显示

通过免费试用版比较任何网站

开始使用
SARCULATOR VS.
Rad Onc Tables

一月 8, 2025